Target intelligence / Profile preview

Proline-rich AKT1 substrate 1 (PRAS40)

Target
PRAS40
Molecular classification
Enzyme substrate (Akt substrate), Regulatory protein, mTOR complex 1 (mTORC1) interacting protein
01

Overview

Proline-rich AKT1 substrate 1 (PRAS40) is a protein encoded by the AKT1S1 gene in humans. It is a prominent substrate of the serine/threonine kinase Akt and an interacting partner of 14-3-3 proteins[4][1]. PRAS40 is also a physiological substrate of the mTOR complex 1 (mTORC1), where it binds to the raptor component and is differentially phosphorylated by mTORC1 and Akt[2]. Functionally, PRAS40 serves as a key modulator of cell survival, proliferation, and NF-κB transcriptional activity, particularly by promoting NF-κB’s transcriptional output and supporting cancer cell growth and survival[3]. It is upregulated and phosphorylated in various cancers, with evidence of altered activity in tumors with p53 and Ras mutations, making it a potential biomarker for early carcinogenesis[1].

Other names
AKT1S1LobeProline-rich Akt substrate of 40 kDaProline-rich Akt-substrate PRAS40
02

Mechanism of action

Inhibitors may regulate mTORC1 signaling via modulation of PRAS40 phosphorylation and interaction

03

Biological functions

Signal transductionCell survivalCell proliferationNF-κB transcriptional activity modulation
04

Disease associations

CancerPossibly other disorders linked to cell proliferation
05

Biomarkers

Early detection marker in carcinogenesis, especially breast and lung cancer

Beyond the preview

Go deeper on Proline-rich AKT1 substrate 1 (PRAS40).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Proline-rich AKT1 substrate 1 (PRAS40).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call